AstraZeneca said on Thursday that there was a higher antibody response against the omicron COVID-19 variant when its vaccine was given as a third booster dose.
The claim comes after new data from trials showed efficacy against the newer form of COVID-19 and previous variants including beta, delta, alpha and gamma.
Developing
